Long-Term Efficacy and Safety of Erenumab: Results From 64 Weeks of the LIBERTY Study.
Peter J GoadsbyUwe ReuterMichel Lanteri-MinetGabriel Paiva da Silva LimaPeggy Hours-ZesigerChrystel FernandesShihua WenNadia TenenbaumAditi KatariaMichel D FerrariJan KlattPublished in: Neurology (2021)
NCT03096834.
Keyphrases